Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Singing mice unlock secrets behind how the brain bends time January 30, 2024 $16M NIH grant to map brain’s wiring diagram September 26, 2023 ATS completes acquisition of Avidity Science August 27, 2024